Bexarotene

Bexarotene is a prescription medicine used to treat a certain type of cancer of the skin called cutaneous T-cell lymphoma (CTCL). It is a type of retinoid, a man-made form of vitamin A. Bexarotene works by slowing or stopping the growth of certain types of cancer cells. It is usually given after other treatments have failed.

Bexarotene, also known by the brand name Targretin, is a medication used to treat a specific type of cancer called cutaneous T-cell lymphoma (CTCL). It belongs to a class of drugs called retinoids, which are related to vitamin A.

Here's a detailed description of Bexarotene:

Purpose:

  • Treats the skin symptoms of CTCL, a rare blood cancer that causes a rash and itchy skin.
  • Not a cure for CTCL, but it can help slow the growth of cancer cells and improve survival rates.
  • Only used for patients whose CTCL has not responded well to other treatments.

Mechanism of action:

  • Bexarotene works by targeting and activating retinoid X receptors (RXRs) in cells.
  • RXRs are involved in regulating cell growth and differentiation.
  • By activating RXRs, bexarotene can slow down the abnormal growth of cancer cells in CTCL.

Dosage and administration:

  • Bexarotene comes in capsule form and is typically taken once daily with or without food.
  • The dosage is determined by your doctor based on your individual needs and tolerability.

Side effects:

  • Bexarotene can cause a variety of side effects, including:
    • Dry skin and lips
    • Skin peeling
    • Increased cholesterol and triglycerides levels
    • Fatigue
    • Loss of appetite
    • Nausea and vomiting
    • Hair loss
    • Bone pain

Important information:

  • Bexarotene can interact with other medications. It is crucial to inform your doctor about all medications you are taking, including prescription and over-the-counter drugs, vitamins, and herbal supplements.
  • Bexarotene can increase sun sensitivity. It is important to wear protective clothing and sunscreen when outdoors to minimize the risk of sunburn.
  • Bexarotene can cause birth defects. Women who are pregnant or planning to become pregnant should not take bexarotene.
Anatomical Therapeutic Chemical Classification
L - Antineoplastic and immunomodulating agents
L01 Antineoplastic agents
L01X - Other antineoplastic agents
L01XF Retinoids for cancer treatment
External Links